<!DOCTYPE html>
<html manifest="manifest.manifest">
<head>
	<meta http-equiv=Content-Type content="text/html; charset=utf-8">
	<title>MRCG Clinical Guidelines</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=2.0, user-scalable=1">
  
	<meta name=Generator content="Microsoft Word 14 (filtered)">
		<link rel="stylesheet" href="jquery.mobile-1.4.5.min.css" />
	<link rel="stylesheet" href="mystyle.css" />
	<script src="jquery-1.11.1.min.js"></script>
	<script src="jquery.mobile-1.4.5.min.js"></script>
	<script type="text/javascript" src="cordova.js"></script>
	<script>
	    		$(function(){
			$("[data-role='header'], [data-role='footer']").toolbar();
		});
  	  $(document).one('pagebeforecreate', function () {
	        $('input[data-type="search"]').val("");
	    	        $.get("panel.html", function (data2) {
            $.mobile.pageContainer.prepend(data2);
              $("[data-role=panel]").panel().enhanceWithin();
        }, "html");
	           $.get("header.html", function (data) {
      $.mobile.pageContainer.prepend(data);
      $("[data-role='header']").toolbar().enhanceWithin();
    }, "html");
    $.get("footer.html", function (data) {
      $.mobile.pageContainer.append(data);
      $("[data-role='footer']").toolbar().enhanceWithin();
    }, "html");
        $('.WordSection1').wrap('<div role="main" class="ui-content">');
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $.mobile.pageContainer.enhanceWithin();
	  });
	        $(document).bind( "pagechange", function( ) {
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $('.tableCont').enhanceWithin();
      } );
			// When the user scrolls down 20px from the top of the document, show the button
		window.onscroll = function() {scrollFunction()};
		function scrollFunction() {
		  if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
			document.getElementById("myBtn").style.display = "block";
		  } else {
			document.getElementById("myBtn").style.display = "none";
		  }
		}
		// When the user clicks on the button, scroll to the top of the document
		function topFunction() {
		  document.body.scrollTop = 0; // For Safari
		  document.documentElement.scrollTop = 0; // For Chrome, Firefox, IE and Opera
		}</script>      

</head>
<body lang=EN-GB link=blue vlink=purple>
	
<div data-role="page">
	<div role="main" class="ui-content">
<div class=WordSection1>
<h1>Stevens-Johnson Syndrome</h1>
<h2>Introduction</h2>
<p class=MsoNormal>Stevens-Johnson syndrome (SJS) and toxic epidermal
necrolysis (TEN) are severe mucoCutaneous adverse reactions, most commonly
triggered by medications, characterized by fever and extensive necrosis and
detachment of the epidermis. SJS and TEN are considered a disease continuum and
are distinguished chiefly by severity, based upon the percentage of body
surface involved with skin detachment.</p>
<p class=MsoNormal>SJS is the less severe condition, in which skin detachment
is &lt;10% of the body surface. Mucous membranes are affected in over 90
percent of patients, usually at two or more distinct sites (ocular, oral, and
genital).</p>
<p class=MsoNormal>TEN involves detachment of &gt;30% of the body surface area.
Mucous membranes are also involved in over 90% of cases.</p>
<p class=MsoNormal>SJS/TEN overlap describes patients with skin detachment of
10 to 30% of body surface area. Mucous membranes are also involved in over 90% of
cases.</p>
<p class=MsoNormal style='margin-top:10.8pt;line-height:140%'><span lang=EN-US>Here,
&quot;SJS/TEN&quot; is used to refer collectively to SJS, TEN, and SJS/TEN
overlap</span><span style='line-height:140%'>. </span></p>
<h2><span lang=EN-US>Target User</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Doctors</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nurses</span></p>
<h2><span lang=EN-US>Target area of use </span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ward</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Outpatient department</span></p>
<h2><span lang=EN-US>Key areas of focus/new additions/changes</span></h2>
<p class=MsoNormal><span lang=EN-US>These guidelines addresses the management
of Stevens Johnson.</span></p>
<h2><span lang=EN-US>Limitations</span></h2>
<p class=MsoNormal><span lang=EN-US>Lack of an intensive care unit to nurse
patient with extensive lesions.</span></p>
<p class=MsoNormal>&nbsp;</p>
<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2>Presenting symptoms and signs</h2>
<p class=MsoNormal>Typical prodromal symptoms of SJS are as follows:</p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Cough productive of a thick, purulent sputum</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Headache</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Malaise</p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Arthralgia</p>
<p class=MsoNormal>Patients may complain of a burning rash that begins
symmetrically on the face and the upper part of the torso. This may be
accompanied by ocular symptoms.</p>
<p class=MsoNormal>In addition to the skin, lesions in SJS may involve the
following parts of the body:</p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Oral mucosa</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Oesophagus</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Pharynx</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Larynx</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Anus</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Trachea</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Vagina</p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Urethra</p>
<p class=MsoNormal>Ocular symptoms include the following: red eye, tearing, dry
eye, pain, blepharospasm, itching, grittiness, heavy eyelid, foreign body
sensation, decreased vision, burning sensation, photophobia, diplopia</p>
<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2>Examination findings</h2>
<p class=MsoNormal>The rash can begin as macules that develop into papules,
vesicles, bullae, urticarial plaques, or confluent erythema. The centre of
these lesions may be vesicular, purpuric, or necrotic.</p>
<p class=MsoNormal>Lesions may become bullous and later rupture, leaving
denuded skin. The skin becomes susceptible to secondary infection. </p>
<p class=MsoNormal>Urticarial lesions typically are not pruritic. Infection may
be responsible for the scarring associated with morbidity.</p>
<p class=MsoNormal>Although lesions may occur anywhere, the palms, soles dorsum
of the hands, and extensor surfaces are most commonly affected.</p>
<p class=MsoNormal>The rash may be confined to any one area of the body, most
often the trunk. Mucosal involvement may include erythema, oedema, sloughing,
blistering, ulceration, and necrosis.</p>
<p class=MsoNormal>The following signs may also be noted on examination:</p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Fever</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Tachycardia</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Hypotension</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Altered level of consciousness, epistaxis</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Conjunctivitis</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Corneal ulceration</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Erosive vulvovaginitis or balanitis</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Seizures</p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Coma</p>
<h2>Differential Diagnoses</h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Trauma</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Irradiation</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Porphyria cutanea tarda</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Staphylococcal scalded skin syndrome</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Sebaceous cell carcinoma</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Adenoviral conjunctivitis</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Intraepithelial epithelioma</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Acute generalized exanthematic pustulosis</p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Chemical burns</p>
<h2>Investigations</h2>
<p class=MsoNormal>There are no specific laboratory studies (other than biopsy)
that can definitively establish the diagnosis of SJS but the following
investigations can be done:</p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>FBC, severely elevated WBC count indicates the possibility of a
superimposed bacterial infection.</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>U&amp;E,LFT may be needed to help manage related problems</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Skin and blood cultures have been advocated because the incidence
of serious bacterial bloodstream infections and sepsis contribute to morbidity
and mortality.</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>CXR may indicate the existence of a pneumonitis when clinically
suspected. Otherwise, routine plain films are not indicated.</p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Skin biopsy specimens demonstrate that the bullae are
subepidermal. Epidermal cell necrosis may be noted. Perivascular areas are
infiltrated with lymphocytes.</p>
<h2>Management</h2>
<p class=MsoNormal><span lang=EN-US style='font-family:"Helvetica","sans-serif"'>The
main principles of supportive care are the same as for major burns and include
wound care, fluid and electrolyte management, nutritional support, temperature
management, pain control, and monitoring or treatment of superinfections</span></p>
<h3>Initiate a primary management plan:</h3>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Establish peripheral venous access:<span style='font-size:9.5pt'>
</span>Site venous lines through non-lesional skin, whenever possible, and
change peripheral venous cannulas every 48 hours.</p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Establish adequate intravenous fluid replacement initially. Fluid
replacement can be guided by urine output and other endpoint measurements.
Individualized fluid management should be adjusted on a daily basis<span
lang=EN-US style='font-family:"Helvetica","sans-serif"'>, but replacement
volumes are approximately one-third lower than those needed for burn victims.</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>With improvement of SJS/TEN mouth involvement, oral
administration of fluids should be progressively increased.</p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-autospace:none'>If patient cannot maintain adequate nutrition
orally, insert a nasogastric tube and institute nasogastric feeding.</p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-size:10.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Insert a urinary catheter if urogenital involvement is causing
significant dysuria/retention.</p>
<h3>Prognostic scoring </h3>
<p class=MsoNormal>The prognosis of individual patients can be rapidly
evaluated on admission by applying a prognostic scoring system called <b>SCORTEN</b>.
SCORTEN is based upon seven independent and easily measured clinical and
laboratory variables<u><span style='color:#00905A'> </span></u>and has been
validated for use on days one and three of hospitalization for SJS/TEN.</p>

  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 width=581
 style='width:435.45pt;border-collapse:collapse;border:none'>
 <tr>
  <td width=245 valign=top style='width:184.05pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b>Prognostic factors </b></p>
  </td>
  <td width=69 valign=top style='width:51.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b>Score</b></p>
  </td>
  <td width=64 valign=top style='width:47.8pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b>&nbsp;</b></p>
  </td>
  <td width=105 valign=top style='width:78.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>SCORTEN</span></b></p>
  </td>
  <td width=98 valign=top style='width:73.75pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-US>Mortality(%)</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=245 valign=top style='width:184.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Age &gt;
  40 years </p>
  </td>
  <td width=69 valign=top style='width:51.4pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>1</p>
  </td>
  <td width=64 valign=top style='width:47.8pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>&nbsp;</p>
  </td>
  <td width=105 valign=top style='width:78.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>0-1</span></p>
  </td>
  <td width=98 valign=top style='width:73.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US>3</span></p>
  </td>
 </tr>
 <tr>
  <td width=245 valign=top style='width:184.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Tachycardia
  &gt;120 bpm </p>
  </td>
  <td width=69 valign=top style='width:51.4pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>1</p>
  </td>
  <td width=64 valign=top style='width:47.8pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>&nbsp;</p>
  </td>
  <td width=105 valign=top style='width:78.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>2</span></p>
  </td>
  <td width=98 valign=top style='width:73.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US>12</span></p>
  </td>
 </tr>
 <tr>
  <td width=245 valign=top style='width:184.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Neoplasia </p>
  </td>
  <td width=69 valign=top style='width:51.4pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>1</p>
  </td>
  <td width=64 valign=top style='width:47.8pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>&nbsp;</p>
  </td>
  <td width=105 valign=top style='width:78.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>3</span></p>
  </td>
  <td width=98 valign=top style='width:73.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US>35</span></p>
  </td>
 </tr>
 <tr>
  <td width=245 valign=top style='width:184.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Initial
  detachment &gt; 10% </p>
  </td>
  <td width=69 valign=top style='width:51.4pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>1</p>
  </td>
  <td width=64 valign=top style='width:47.8pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>&nbsp;</p>
  </td>
  <td width=105 valign=top style='width:78.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>4</span></p>
  </td>
  <td width=98 valign=top style='width:73.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US>58</span></p>
  </td>
 </tr>
 <tr>
  <td width=245 valign=top style='width:184.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Serum urea
  &gt; 10 mmol/L </p>
  </td>
  <td width=69 valign=top style='width:51.4pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>1</p>
  </td>
  <td width=64 valign=top style='width:47.8pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>&nbsp;</p>
  </td>
  <td width=105 valign=top style='width:78.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>&#8805;5</span></p>
  </td>
  <td width=98 valign=top style='width:73.75pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US>90</span></p>
  </td>
 </tr>
 <tr>
  <td width=245 valign=top style='width:184.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Serum
  bicarbonate &lt; 20 mmol/L </p>
  </td>
  <td width=69 valign=top style='width:51.4pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>1</p>
  </td>
  <td width=64 valign=top style='width:47.8pt;border:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>&nbsp;</p>
  </td>
  <td width=105 valign=top style='width:78.45pt;border:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>&nbsp;</p>
  </td>
  <td width=98 valign=top style='width:73.75pt;border:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=245 valign=top style='width:184.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Blood
  glucose &gt; 14 mmol/L</p>
  </td>
  <td width=69 valign=top style='width:51.4pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>1</p>
  </td>
  <td width=64 valign=top style='width:47.8pt;border:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>&nbsp;</p>
  </td>
  <td width=105 valign=top style='width:78.45pt;border:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>&nbsp;</p>
  </td>
  <td width=98 valign=top style='width:73.75pt;border:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'>&nbsp;</p>
  </td>
 </tr>
</table>
<p class=MsoNormal><span class=h23><u><span lang=EN-US style='font-family:"Helvetica","sans-serif"'><span
 style='text-decoration:none'>&nbsp;</span></span></u></span></p>
<p class=MsoNormal><span lang=EN-US style='font-family:"Helvetica","sans-serif"'>The
decision to refer the patient to an intensive care or burn unit should be made
on a case-by-case basis, based upon the extent of skin involvement and the
presence of comorbidities. Patients with a limited skin involvement, a SCORTEN
score<u><span style='color:#00905A'> </span></u>of 0 or 1, and disease that is
not rapidly progressing may be treated in nonspecialized wards. Patients with
more severe disease (skin detachment &gt;30% of the body surface area) <strong><span
style='font-family:"Helvetica","sans-serif"'>or</span></strong> a SCORTEN score
&#8805;2 should be transferred to intensive care units, burn units, or
specialized dermatology units, if available.</span></p>
<h3><span lang=EN-US>Skin Care</span><span lang=EN-US style='color:black'> </span></h3>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Employ strict barrier nursing to reduce
nosocomial infections</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Take swabs for bacterial and candidal
culture from three areas of lesional skin, particularly sloughy or crusted
areas, on alternate days throughout the acute phase.</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Administer systemic antibiotics only if
there are clinical signs of infection</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Regularly cleanse wounds and intact
skin by irrigating gently using warmed sterile water, saline or an
antimicrobial such as chlorhexidine (1/5000)</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Apply a greasy emollient, such as
emulsifying ointment, 50% white soft paraffin with 50% liquid paraffin (50/50WSP/LP),
over the whole epidermis, including denuded areas</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Apply a topical antimicrobial agent to
sloughy areas only (choice should be guided by local microbiological advice·</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>The detached, lesional epidermis may be
left <i>in situ </i>to act as a biological dressing. Blisters should be
decompressed by piercing and expression or aspiration of tissue fluid.</span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Apply non-adherent dressings to denuded
dermis </span></p>
<h3>Analgesia</h3>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Use a patient appropriate validated
pain tool to assess pain in all conscious patients at least once a day.</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'> Patients should receive adequate
analgesia to ensure comfort at rest, with the addition of supplementary
opiates, as required.</span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Additional analgesia may be needed to
address increased pain associated with patient handling, re-positioning and
dressing changes</span></p>
<h3>Supportive therapeutic measures</h3>
<p class=MsoListParagraphCxSpFirst style='margin-left:32.2pt;text-indent:-18.0pt'><span
style='font-family:Symbol;color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Immobile patients should receive low
molecular weight heparin</span></p>
<p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:32.2pt;margin-bottom:.0001pt;text-indent:-18.0pt;
text-autospace:none'><span style='font-family:Symbol;color:black'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Patients in whom enteral nutrition
cannot be established should receive a proton pump inhibitor to reduce the risk
of stress-related gastro-intestinal ulceration</span></p>
<h3>Ocular Care</h3>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Apply an ocular lubricant (e.g.
non-preserved hyaluronate or carmellose eye drops) every two hours through the
acute illness</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Ocular hygiene must be carried out each
day</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Application of topical corticosteroid
drops (e.g. non-preserved dexamethasone 0.1% twice a day) may reduce ocular
surface damage</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Administer  topical antibiotic as
prophylaxis (e.g. ciprofloxacin drops four times a day) in the presence of
corneal ulceration</span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>In the unconscious patient, prevention
of corneal exposure is essential.</span></p>
<h3>Mouth care</h3>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Daily oral review is necessary during
the acute illness</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Apply white soft paraffin ointment to
the lips every two hours through the acute illness</span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Clean the mouth daily with warm saline
mouthwashes or an oral sponge</span></p>
<h3>Urogenital Care<span style='color:white'>t</span></h3>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Daily urogenital review is necessary
during the acute illness</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Apply white soft paraffin ointment to
the urogenital skin and mucosae every four hours throughout the acute illness</span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Use a potent topical corticosteroid
ointment once a day to the involved, but non-eroded surfaces.</span></p>
<h3>Nutritional care<span style='color:white'> of airway</span></h3>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Provide continuous enteral nutrition throughout the acute phase</p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Deliver up to 20 to 25 kcal/kg/day during the early, catabolic
phase and 25 to 30 kcal/kg/day during the anabolic, recovery phase.</p>
<h3>Discharge and follow up</h3>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Give the patient written information
about drug(s) to avoid</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Drug allergy should be documented in
the patient’s notes; all doctors involved in the patient’s care should be
informed</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt;text-autospace:none'><span style='font-family:Symbol;
color:black'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Organize an out-patient clinic
appointment, and if required an ophthalmology out-patient appointment, within a
few weeks of discharge</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='color:black'>Refer for review to unit with</span>
appropriate sub-speciality interest</p>
<h2>Key Issues for Nursing care</h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Sterile handling and/or reverse-isolation nursing techniques are
essential to decrease the risk of nosocomial infection</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Daily ocular and mouth hygiene</p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Effective and timely skin care</p>
<h2 style='margin-bottom:6.0pt'>References</h2>
<p class=MsoNormal style='margin-left:12.0pt;text-indent:-18.0pt'><span
style='font-size:10.0pt;color:black'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US><a
href="https://www.uptodate.com/contents/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-management-prognosis-and-long-term-sequelae/abstract/1"><span
lang=EN-GB style='font-size:10.0pt;color:black;text-decoration:none'>Bastuji-Garin
S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic
epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch
Dermatol 1993; 129:92.</span></a></span></p>
<p class=MsoNormal style='margin-left:12.0pt;text-indent:-18.0pt'><span
style='font-size:10.0pt;color:black'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US><a
href="https://www.uptodate.com/contents/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-management-prognosis-and-long-term-sequelae/abstract/2"><span
lang=EN-GB style='font-size:10.0pt;color:black;text-decoration:none'>Creamer D,
Walsh SA, Dziewulski P, et al. U.K. guidelines for the management of
Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016. Br J
Dermatol 2016; 174:1194.</span></a></span></p>
<p class=MsoNormal style='margin-left:12.0pt;text-indent:-18.0pt'><span
style='font-size:10.0pt;color:black'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US><a
href="https://www.uptodate.com/contents/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-management-prognosis-and-long-term-sequelae/abstract/3"><span
lang=EN-GB style='font-size:10.0pt;color:black;text-decoration:none'>Harr T,
French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J
Rare Dis 2010; 5:39.</span></a></span></p>
<p class=MsoNormal style='margin-left:12.0pt;text-indent:-18.0pt'><span
style='font-size:10.0pt;color:black'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US><a
href="https://www.uptodate.com/contents/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-management-prognosis-and-long-term-sequelae/abstract/4"><span
lang=EN-GB style='font-size:10.0pt;color:black;text-decoration:none'>Bastuji-Garin
S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity-of-illness score for
toxic epidermal necrolysis. J Invest Dermatol 2000; 115:149.</span></a></span></p>
<p class=MsoNormal style='margin-left:12.0pt;text-indent:-18.0pt'><span
style='font-size:10.0pt;color:black'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:10.0pt'>UK guidelines for the management
of Stevens-Johnson syndrome/toxic epidermal necrolysis 2016</span><span
style='font-size:10.0pt;color:black'> </span><span style='font-size:10.0pt'>Creamer
D, Walsh SA , Dziewulski P, Exton LS, Lee HY, Dart JKG, Setterfield J, Bunker
CB, Ardern-Jones MR, Watson KMT,Wong GAE, Philippidou M, Vercueil A, Martin RV,
Williams G, Shah M, Brown D, Williams P, Mohd Mustapa MF, Smith CH.</span></p>
<p class=MsoNormal style='margin-left:12.0pt;text-indent:-18.0pt'><span
style='font-size:10.0pt;color:black'>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><i><span style='font-size:10.0pt'>Br J Dermatol </span></i><b><span
style='font-size:10.0pt'>2016</span></b><span style='font-size:10.0pt'>; 174:
1194-1227 &amp; <i>J Plast Reconstr Aesthet Surg </i><b>2016</b>; 69: e119e153</span></p>
<div class="tableCont">
  <table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Written
  by:</b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Name: Amie
  Secka</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Date: 30
  November 2018</p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Reviewed
  by:</b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Name: Orighomisan
  Agboghoroma</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Date: 06
  December 2018 </p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Version:</b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Change
  history:</b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Review
  due date:</b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>1.0</p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>New
  document</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>31 January
  2021</p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Review
  Comments (<i>if applicable)</i></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>&nbsp;</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>&nbsp;</b></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal>&nbsp;</p>
</div>
</div><!-- /content -->

</div>

</body>
</html>
